In an attempt to increase Chlamydiazyme (Abbott Laboratories) detection of Chlamydia trachomatis antigen and to establish the reproducibility of positive results, we carried out an investigation into the usefulness of testing duplicate specimens, of more aggressive endocervical specimen collection by using cytobrushes instead of swabs, and of the repeated testing of both specimens from patients with one or two positive results. Duplicate endocervical (female) and urethral (male) specimens, including one swab and one cytobrush specimen from 1,331 nonpregnant women, were collected from symptomatic and asymptomatic patients. Specimens were transported and tested for C. trachomatis antigen as specified by the manufacturer. Tests on all specimens from patients with positive results were repeated. Antigen was initially detected in one or both specimens from 210 (10.7%) of 1,968 patients, and repetition of the tests confirmed its presence in 198 (10.1%) of the patients, including all 183 patients in whom it was initially detected in both specimens. Initial results from at least 8 of the 12 patients with irreproducible antigen detection were most probably falsely positive. Results from 21 (10.6%) of the 198 patients for whom antigen detection was confirmed were repeatedly positive on only one specimen (9 [4.5%] on the second of the two specimens collected). Of 115 women from whom one swab and one cytobrush sample were taken and who had repeatedly positive results, antigen was detected in 7 (6.1%) only on the swab sample and in 4 (3.5%) only on the cytobrush sample. Use of the cytobrush does not appear justified with the Chlamydiazyme assay, and collection of duplicate specimens provided only a modest increase in detection of C. trachomatis. However, repeated testing of specimens when results from only one of two specimens are positive appears to be of clinical value.
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In comparison with cell culture methods, the reported sensitivity and specificity of the Chlamydiazyme test (Abbott Laboratories, North Chicago, Ill.) for detection of Chlamydia trachomatis range from 44 to 100% and from 92.9 to 98.1%, respectively, with cervical specimens (1, 2, 4, 9-11, 14, 16, 17, 20) and from 47.8 to 92% and from 90 to 100%, respectively, with male urethral specimens (4, 9, 10, 13, 14, 17) . This enzyme immunoassay procedure appears to be less sensitive than culture methods when the specimen contains few organisms (4, 9, 17, 20) . In addition, falsepositive results, causing potentially difficult medical and social problems, have been reported (7) .
Because of the technical simplicity, the ability to batch large numbers of tests, and the speed of reporting associated with the Chlamydiazyme procedure, we have undertaken a study of ways to increase the detection of C. trachomatis antigen by using this product and to establish the reproducibility of positive results. The study consisted of an investigation into the usefulness of collection and testing of duplicate specimens, more aggressive endocervical specimen collection by using cytobrushes instead of swabs, and repeated testing of both specimens from patients with one or two positive results.
MATERIALS AND METHODS
From 22 June 1987 until 9 March 1988, duplicate genital specimens for C. trachomatis antigen detection were obtained from asymptomatic and symptomatic patients suspected clinically of having sexually transmitted disease. If a * Corresponding author. specimen was to be collected for recovery of Neisseria gonorrhoeae, it was taken first. After removal of exocervical mucus, two consecutive STD-EZE cotton swabs (Abbott) were inserted into the endocervical canal of pregnant patients, rotated, and placed into their individual transport tubes, labeled no. 1 and 2 in order of collection. For nonpregnant females, a swab and then a cytobrush (Syva Co., Palo Alto, Calif.) were used to obtain endocervical specimens. The order of collecting the swab and cytobrush specimens was reversed partway through the study. For male patients, two consecutive STD-PEN cotton swabs (Abbott) were inserted 2 to 4 cm into the urethra, rotated, and placed into individual transport tubes with the order of collection specified.
Specimens were stored in their transport tubes at 4 to 80C and tested for C. trachomatis antigen within 72 h by using the Chlamydiazyme procedure (Abbott) as specified by the manufacturer. Specimen dilution buffer (1 ml) was added to each specimen, and after 10 to 15 min, 200 1tI of the vortexed specimen and controls were reacted in sequence with beads containing antibody to C. trachomatis (37°C for 60 min), rabbit antibody to C. trachomatis (37°C for 60 min), horseradish peroxidase-conjugated antibody to rabbit immunoglobulin G (370C for 60 min), and O-phenylenediamine (25°C for 30 min). The reactions were terminated with 1 N sulfuric acid. Reaction beads were washed by using the Proquantum (Abbott), and the A492 was determined on the Quantumatic spectrophotometer (Abbott). A result was considered positive when the A492 reading was greater than or equal to the mean of three negative controls plus 0.100 nm. Tests on all specimens from patients with positive or discrepant (one b Tests on both specimens were repeated when the result of only one of two was positive.
positive, one negative) results were repeated (in duplicate when volume permitted) within 48 h for confirmation.
The Z test for differences in proportions was used for statistical analysis of results (3) . Confidence intervals for a true response probability were calculated by using equation 1 of Simon (18) .
RESULTS
Material and labor costs associated with the Chlamydiazyme assay when different collection and processing procedures were followed (as compared with the procedure recommended by the manufacturer) are shown in Table 1 . Duplicate genital specimens were obtained from 1,968 patients, who ranged in age from 3 to 79 years (mean, 24.7 years; median, 23 years). C. trachomatis antigen was initially detected in specimens from 210 (10.7%) of the patients (in both specimens from 183 [87.1%] of these patients and in only one of two specimens from the remaining 27 [12.8%]).
The age range of these patients was 13 to 49 years (mean, 20.7 years; median, 20 years). Repetition of the test confirmed the presence of antigen in 198 (10.1%) of the patients; in 21 (10.6%) of these, repeated detection of antigen occurred for only one of the two specimens (Table 2) . One or both specimens were repeatedly positive for 42 (9.1%) of 460 asymptomatic females, 151 (10.4%) of 1,454 symptomatic females, and 5 (9.2%) of 54 symptomatic males.
Repeatability of results. Among the 210 patients in whom antigen was initially detected, results for both specimens A decrease of 5 to 6% in the mean A492 was observed when tests on specimens with positive results were repeated (-0.055 with swabs collected first, -0.070 with swabs collected second, and -0.056 with the cytobrushes). All results which were initially negative remained negative when tests on specimens from the 27 patients with discrepant results were repeated.
Relative value of the cytobrush and of duplicate specimens. Of 115 female patients from whom samples were taken with both a swab and a cytobrush and from whom repeatedly positive results were obtained, positive results from 4 (3.5%) were obtained only with the cytobrush, whereas positive results from 7 (6.1%) were obtained only with the swab (not significant) (Table 3 ). However, antigen was detected only in the specimen collected second from at least 9 (4.5%; 95% confidence limit, 2.4 to 8.4%) and as many as 14 (7.1%; 95% confidence limit, 4.8 to 11.3%) of the 198 patients with confirmed positive results (depending on the true order of specimen collection from the 5 patients who had only one positive result and for whom the actual order of duplicate specimen collection could not be determined). Therefore, the use of a second specimen collection device resulted in an increase of at least 4.8% (9 of 189) to 7.6% (14 of 184) in the number of patients with repeatedly positive results. The mean A492 associated with positive results was similar among the specimen collection devices (1.125 for swabs collected first, 1.141 for swabs collected second, and 1.132 for cytobrushes). DISCUSSION Aggressive endocervical specimen collection with a scraper has been reported to significantly increase the recovery of C. trachomatis in culture (5). However, no increase was reported in numbers of patients with positive direct fluorescent-antibody smears when cytobrushes were used rather than swabs (although more elementary bodies were frequently detected from cytobrush specimens) (12 of using a cytobrush, including increased cost (Table 1) and potential risks to pregnant patients (12) .
The relative value of multiple genital specimens for detection of C. trachomatis appears to be related, at least in part, to the number of specimens collected and to the type of assay system used. Reported increases in the number of infected patients detected by the use of multiple specimens have ranged from 5% to as high as 69% when cultures were inoculated (5, 6, 15, 19) but from 0% to only 9% (8, 17) when the Chlamydiazyme method was used. Multiple specimens may be more effective for detection of C. trachomatis when used with culture because of the amplification effect of culture and its greater ability to detect very small numbers of organisms in a specimen (4, 9, 17, 20) . The second specimen collected in the current study was the only repeatedly positive specimen from at least 9 (4.5%) and as many as 14 (7.1%) of the 198 patients with repeatedly positive results.
The small drop (5 to 6%) in A492 frequently observed when tests on specimens with positive results were repeated was most probably due to instability of the C. trachomatis antigen during storage. Repeating a Chlamydiazyme test was of no diagnostic value for 183 (87.1%) of the 210 patients for whom positive results were initially obtained. Results with both specimens from these 183 patients were positive when initially tested, and results with at least one of the two specimens remained positive when the tests were repeated. 
